Zydus Lifesciences Secures USFDA Approval for Advanced Transdermal Hormone Therapy
The medicine is approved for treating moderate-to-severe vasomotor symptoms associated with menopause, including hot flashes. It is also indicated for preventing postmenopausal osteoporosis in appropriate patients.